In addition, recent genome-wide association studies identified UGT2B17 as an effector gene for circulating levels of total cholesterol, apolipoprotein B [53], low density lipoprotein-cholesterol [52] and triglycerides [57] as well as associations between androgen levels and metabolic diseases [58]. Here, UGT2B17 is linked to metabolic disease.